Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults (Q43456332)
scientific article published on March 26, 1998
Language:
Current Data About Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults
(P31) (Q13442814)
(P248)
(P698) 9543445
(P813) Thursday, November 23, 2017

(P50) (Q56334424)
(P1545) 3
(P1932) A. Ammassari
(P248)
(P698) 9543445
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9543445
(P813) Tuesday, December 17, 2024

(Q62568867)
(P1545) 6
(P1932) A. Antinori
(P248)
(P698) 9543445
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9543445
(P813) Tuesday, December 17, 2024

(Q57385925)
(P1545) 7
(P1932) E. Tamburrini
(P248)
(P698) 9543445
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9543445
(P813) Tuesday, December 17, 2024

(Q56451079)
(P1545) 10
(P1932) S. Vella
(P248)
(P698) 9543445
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9543445
(P813) Tuesday, December 17, 2024

(P304) 473-480
(P248)
(P698) 9543445
(P813) Thursday, November 23, 2017

(P407) (Q1860)

(P433) 5
(P248)
(P698) 9543445
(P813) Thursday, November 23, 2017

(P478) 12
(P248)
(P698) 9543445
(P813) Thursday, November 23, 2017

(P577) Sunday, March 1, 1998
(P248)
(P698) 9543445
(P813) Thursday, November 23, 2017

Thursday, March 26, 1998
(P248)
(P698) 9543445
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9543445
(P813) Tuesday, December 17, 2024

(P921) (Q42824440)

(Q1415366)

(P953) https://journals.lww.com/aidsonline/Fulltext/1998/05000/Phase_II_controlled_trial_of_post_exposure.8.aspx
(P2701)
(P6954)
(P248)
(P698) 9543445
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9543445
(P813) Tuesday, December 17, 2024

https://journals.lww.com/00002030-199805000-00008
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(P1433) (Q4651863)
(P248)
(P698) 9543445
(P813) Thursday, November 23, 2017

(P1476) "Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol Team" (language: en)
(P248)
(P698) 9543445
(P813) Thursday, November 23, 2017

"Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults" (language: en)
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(P2093) O. Pontesilli
(P1545) 1
(P248)
(P698) 9543445
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9543445
(P813) Tuesday, December 17, 2024

E. C. Guerra
(P1545) 2
(P248)
(P698) 9543445
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9543445
(P813) Tuesday, December 17, 2024

C. Tomino
(P1545) 4
(P248)
(P698) 9543445
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9543445
(P813) Tuesday, December 17, 2024

M. Carlesimo
(P1545) 5
(P248)
(P698) 9543445
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9543445
(P813) Tuesday, December 17, 2024

A. Prozzo
(P1545) 8
(P248)
(P698) 9543445
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9543445
(P813) Tuesday, December 17, 2024

A. C. Seeber
(P1545) 9
(P248)
(P698) 9543445
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9543445
(P813) Tuesday, December 17, 2024

L. Ortona
(P1545) 11
(P248)
(P698) 9543445
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9543445
(P813) Tuesday, December 17, 2024

F. Aiuti
(P1545) 12
(P248)
(P698) 9543445
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9543445
(P813) Tuesday, December 17, 2024

(P2860) (Q59075583)
(P1545) 1
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q46879617)
(P1545) 2
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q45860645)
(P1545) 3
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q6294722)
(P1545) 4
(P478) 172
(P304) 367
(P2093) Wahren
(P577) Saturday, January 1, 1994
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q44422362)
(P1545) 5
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q52052815)
(P1545) 7
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q40880917)
(P1545) 10
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q37313358)
(P1545) 11
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q71849285)
(P1545) 12
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q45771324)
(P1545) 13
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q45767635)
(P1545) 15
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q39439717)
(P1545) 16
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q44592013)
(P1545) 17
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q52845358)
(P1545) 18
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q29619980)
(P1545) 19
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q73321254)
(P1545) 20
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q28302762)
(P1545) 21
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

(Q73034306)
(P1545) 22
(P248)
(P356) 10.1097/00002030-199805000-00008
(P854) https://api.crossref.org/works/10.1097/00002030-199805000-00008
(P813) Tuesday, December 17, 2024

other details
description scientific article published on March 26, 1998

External Links
(P356) 10.1097/00002030-199805000-00008
(P698) 9543445